2020 Avera Cancer Institute Oncology Symposium


2020 Avera Cancer Institute Oncology Symposium Banner

Add to Calendar 2020 Avera Cancer Institute Oncology Symposium 10/2/2020 8:00:00 AM 10/2/2020 3:45:00 PM America/Chicago For More Details: https://avera.cloud-cme.com/course/courseoverview?EID=15307 Description: The Avera Cancer Institute Oncology Symposium is designed to enhance collaboration between the provider and the multidisciplinary team in caring for individuals with cancer across the continuum of care. Virtual (WebEx) false MM/DD/YYYY


Date & Location
Friday, October 2, 2020, 8:00 AM - 3:45 PM, Virtual (WebEx)

Registration

Please register for this conference at no charge.  Information to attend virtually will be shared with registered attendees.  

 

When it's time, join your Webex meeting here.

 

 

Meeting number (access code): 133 221 6797

Meeting password: tBUdpndK328

 

 

Join meeting

 

Tap to join from a mobile device (attendees only) 
+1-312-535-8110,,1332216797## United States Toll (Chicago) 
+1-469-210-7159,,1332216797## United States Toll (Dallas) 

Join by phone 
+1-312-535-8110 United States Toll (Chicago) 
+1-469-210-7159 United States Toll (Dallas) 
Global call-in numbers 
 
Join by video system, application or Skype for business
Dial [email protected] 
You can also dial 173.243.2.68 and enter your meeting number.   


Overview
The Avera Cancer Institute Oncology Symposium is designed to enhance collaboration between the provider and the multidisciplinary team in caring for individuals with cancer across the continuum of care.

ACCME Objectives
  1. Develop new patterns of thought that naturally veer toward kindness. (Phillips)
  2. Explain methods to diffuse difficult situations with kindness. (Phillips)
  3. The learner will be able to describe the role of chimeric antigen receptor therapy in the treatment of hematologic oncology patients. (Parameswaran)
  4. Describe the latest in the treatment of Hepatocellular Carcinoma using catheter directed radioembolization. (Yim)
  5. Describe the psychosocial impact of cancer and treatments on reproductive health of young cancer survivors. (Hunter)
  6. Describe the role of palliative care in advanced cancer care. (Arneson)
  7. Compare the generic and biosimilar medication development process. (Lockhorst)
  8. Identify practical challenges of biosimilar use including interchangeability, formulary restrictions, prescribing, dispensing, and research (Lockhorst)
  9. Describe how a specialty pharmacy uses clinical data to report and document interventions (Wollman)
  10. Identify effective methods to assist with patient adherence to medication regimens. (Wollman)
  11. Describe the expected outcomes of rectal cancer treatment (Guardodo)
  12. Explain the appropriate types of rectal cancer management (Guardado)
  13. Identify benefits and risks to consider for various types of treatment (Guardado)
  14. Identify the various risk factors associated with breast cancer (Bryan)
  15. Describe which factors can be controlled or changed to help reduce risk (Bryan)

ANCC Learning Outcomes
  1. Develop new patterns of thought that naturally veer toward kindness. (Phillips)
  2. Explain methods to diffuse difficult situations with kindness. (Phillips)
  3. The learner will be able to describe the role of chimeric antigen receptor therapy in the treatment of hematologic oncology patients. (Parameswaran)
  4. Describe the latest in the treatment of Hepatocellular Carcinoma using catheter directed radioembolization. (Yim)
  5. Describe the psychosocial impact of cancer and treatments on reproductive health of young cancer survivors. (Hunter)
  6. Describe the role of palliative care in advanced cancer care. (Arneson)
  7. Compare the generic and biosimilar medication development process. (Lockhorst)
  8. Identify practical challenges of biosimilar use including interchangeability, formulary restrictions, prescribing, dispensing, and research (Lockhorst)
  9. Describe how a specialty pharmacy uses clinical data to report and document interventions (Wollman)
  10. Identify effective methods to assist with patient adherence to medication regimens. (Wollman)
  11. Describe the expected outcomes of rectal cancer treatment (Guardodo)
  12. Explain the appropriate types of rectal cancer management (Guardado)
  13. Identify benefits and risks to consider for various types of treatment (Guardado)
  14. Identify the various risk factors associated with breast cancer (Bryan)
  15. Describe which factors can be controlled or changed to help reduce risk (Bryan)

Additional Information
ADA accommodations will be made in accordance with the law. If you require ADA accommodations, please indicate what your needs are at the time of registration. We cannot ensure the availability of appropriate accommodations without prior notification.

Accreditation

CME Accreditation Statement: 
Avera is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  Application has been made for continuing medical education.

CNE Accreditation Statement: 
Avera Health is an Approved Provider of nursing continuing professional development by The Alabama State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider #5-160.

Social Work Accreditation Statement:
Avera Health Provider #1029 is approved as a provider for continuing education by the South Dakota Board of Social Work Examiners.  Application has been made for continuing education hours.

ASRT Statement:
Approved by the ASRT for Category A continuing education credit.

South Dakota Board of Pharmacy Statement:
Approved by the South Dakota Board of Pharmacy for continuing education credit.